Pfizer (PFE) has seen its stock price move gradually higher over the past week, rising nearly 15% in that period. Investors seem interested in the company’s recent performance and underlying ...
Pfizer's revenue has stabilized, and a recent drug pricing deal with the US government reduces political uncertainty. Find ...
Zacks Investment Research on MSN
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...
Zacks.com on MSN
Here's Why Pfizer (PFE) Fell More Than Broader Market
Pfizer (PFE) closed at $25.24 in the latest trading session, marking a -1.71% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.28% for the day. Elsewhere, the ...
WASHINGTON, DC - SEPTEMBER 30: Pfizer CEO Albert Bourla speaks shakes hands with U.S. President Donald Trump as Centers for Medicare & Medicaid Services Mehmet Oz looks on after Trump announced a deal ...
Could this finally be it? Be what, you may ask? Obviously, I'm talking about the redemption of the much-battered biopharma leader that we all know about; Pfizer Inc. (NYSE:PFE). The pharma giant ...
Pfizer (PFE) concluded the recent trading session at $24.51, signifying a +1.16% move from its prior day's close.
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Health Care ETF (Symbol: VHT) where we have detected an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback